Chinese licensing partnerships are becoming both more common and more valuable, but the overall deal value for China remains relatively small.
We analyzed 92 licensing deals for pharmaceutical products in which China was the major territory for a foreign partner.
Some of the details contained in this report include:
Discover if partnering in China will be worthwhile for your company.
Get the PDF:
Pharma Partnering in China: What is a Deal Worth?